Financial Results for the Fiscal Year Ended March 31, 2023 (FY2022)
May 15, 2023
Naoki Muto
Chief Accounting and Financial Officer Terumo Corporation
Safe Harbor for Forward-Looking Statements and Use of Document
Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. Information about products (including products currently in development) which is included in this material is not intended to constitute an advertisement or medical advice.
©TERUMO CORPORATION | 2 / 27 |
Highlights
FY22 Revenue
Highest-ever sales revenue and OP; profit for the period increased US drove sales revenue growth; +5% group-wide (excluding FX)
Profit temporarily down in Q4; shortfall against Feb. guidance
FY23 guidance
Continued global growth, +6% sales revenue growth (excluding FX) Expand high-margin products for double-digit OP growth
©TERUMO CORPORATION | 3 / 27 |
P&L
Revenue: Highest ever. Strong demand continued in C&V field, especially US
OP: Although highest ever, impact from raw materials price increases and one-time Q4 costs drove profitability down
100M JPY | FY 21 Q4 YTD | FY 22 Q4 YTD Change | Change excluding | |
FX impact | ||||
Revenue | 7,033 | 8,202 | 17% | 5% |
Gross Profit | 3,693 | 4,174 | 13% | 2% |
(%) | (52.5%) | (50.9%) | ||
SG&A Expenses | 1,991 | 2,383 | 20% | 7% |
(%) | (28.3%) | (29.1%) | ||
R&D Expenses | 518 | 616 | 19% | 7% |
(%) | (7.4%) | (7.5%) | ||
Other Income and Expenses | -25 | -2 | - | - |
Operating Profit | 1,160 | 1,173 | 1% | -5% |
(%) | (16.5%) | (14.3%) | ||
Adjusted Operating Profit | 1,344 | 1,380 | 3% | -6% |
(%) | (19.1%) | (16.8%) | ||
Profit before Tax | 1,145 | 1,161 | 1% | |
(%) | (16.3%) | (14.2%) | ||
Profit for the Year | 888 | 893 | 1% | |
(%) | (12.6%) | (10.9%) | ||
Average exchange rate (USD/EUR) | 112JPY/131JPY 135JPY/141JPY |
FY21 Q4 | FY22 Q4 | Change |
1,798 | 2,022 | 12% |
905 | 990 | 9% |
(50.3%) | (49.0%) | |
528 | 597 | 13% |
(29.4%) | (29.5%) | |
144 | 160 | 11% |
(8.0%) | (7.9%) | |
-18 | 5 | - |
215 | 238 | 11% |
(12.0%) | (11.8%) | |
273 | 284 | 4% |
(15.2%) | (14.1%) | |
215 | 240 | 12% |
(11.9%) | (11.9%) | |
171 | 191 | 12% |
(9.5%) (9.5%) 116JPY/130JPY 132JPY/142JPY
©TERUMO CORPORATION | 4 / 27 |
Operating Profit Variance Analysis (Q4 YTD)
(100M JPY)
Gross | Pricing | ||
G/P | margin | ||
+27 SG&A | FX | ||
increment | Reimbur- | R&D | |
by | |||
sales | sement | ||
increase | price, etc. | ||
-28 |
FY21 | FY21 | FY22 | FY22 |
Q4 YTD | Q4 YTD | Q4 YTD | Q4 YTD |
Operating Adjusted | Adjusted Operating | ||
Profit | Operating | Operating | Profit |
Profit | Profit |
GP increment by sales increase:
Increased demand and new product contribution grew sales
Gross margin:
Unprecedented raw materials price increases etc. continued
Price:
Price increases that we continued through the period insufficient to make up for negative impact
SG&A, R&D:
Expense control while continuing investment in growth fields
FX:
Large positive impact due to yen depreciation
©TERUMO CORPORATION | 5 / 27 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Terumo Corporation published this content on 15 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 May 2023 06:27:02 UTC.